Hydrogen Peroxide Mediates Hyperglycemia-Enhanced Invasive Ability of Pancreatic Cancer Cells Via Erk and P38 Mapk Pathways

Wei Li,Liang Han,Qingyong Ma

DOI: https://doi.org/10.1093/annonc/mdt203.39

IF: 51.769

2013-01-01

Annals of Oncology

Abstract:Background: Pancreatic cancer is one of the most lethal malignant diseases with a dismal 5-year survival rate. Although surgery remains the only way to cure this disease, almost 80% patients are not suitable for surgical resection at the time of initial diagnosis because of locally deteriorated or metastatic disease. Diabetes mellitus and pancreatic cancer are intimately related that approximately 85% pancreatic cancer patients are suffered from glucose intolerance or even frank diabetes. Our previous study has demonstrated that hyperglycemia promoted the invasive and migratory activity of pancreatic cancer cells. The aim of the present study was to evaluate the underlying mechanism through which hyperglycemia modulated the invasive potential of cancer cells, contributing to their enhanced metastatic behavior. Methods: A hydrogen peroxide (H2O2) assay kit was used to test the level of H2O2. The expression of phospho-p38 and phospho-ERK1/2 was measured by Western blotting in the pancreatic cancer cells. The mRNA and protein levels of an invasion-related factor, urokinase plasminogen activator (uPA), was measured by realtime-PCR and Western blotting. Transwell invasion assay was used to detect the invasive potential of cancer cells. Results: Our results showed that hyperglycemia activated both p38 MAPK and ERK pathways in a time-dependent manner in pancreatic cancer cells. The intracellular H2O2 production was increased in high glucose-cultured cells and could be inhibited by treatment with an H2O2 scavenger, polyethylene glycol (PEG)-catalase. In addition, PEG-catalase diminished high glucose-induced p38 MAPK and ERK1/2 phosphorylation in pancreatic cancer cells. Furthermore, we also showed that hyperlycemia-induced cell invasive ability was abolished by treatment with SB 203580, PD 98059 and PEG-catalase. Finally, we indicated that hyperglycemia-enhanced expression of uPA could also be inhibited by treatment with SB 203580, PD 98059 and PEG-catalase. Conclusion: This study demonstrates a novel mechanism in which high glucose enhances invasive ability through the production of H2O2 as well as activation of p38 MAPK and ERK pathways in human pancreatic cancer cells.